March 2, 2010
Posted by admin
RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt’s Macular Dystrophy
Press Release Source: Advanced Cell Technology, Inc. On Tuesday March 2, 2010, 9:00 am EST
WORCESTER, Mass.–(BUSINESS WIRE)–Advanced Cell Technology, Inc. (OTCBB: ACTC - News), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company’s MA09-hRPE cells for use in the treatment [...]